228 related articles for article (PubMed ID: 23837158)
1. Basal cell carcinoma: hedgehog pathway inhibitors and beyond.
Walls B
Cutis; 2013 Jun; 91(6):E1-4. PubMed ID: 23837158
[No Abstract] [Full Text] [Related]
2. Harnessing hedgehog for the treatment of basal cell carcinoma.
Harms KL; Dlugosz AA
JAMA Dermatol; 2013 May; 149(5):607-8. PubMed ID: 23677088
[No Abstract] [Full Text] [Related]
3. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway.
Sekulic A; Mangold AR; Northfelt DW; LoRusso PM
Curr Opin Oncol; 2013 May; 25(3):218-23. PubMed ID: 23493193
[TBL] [Abstract][Full Text] [Related]
4. Hedgehog- and mTOR-targeted therapies for advanced basal cell carcinomas.
Piérard-Franchimont C; Hermanns-Lê T; Paquet P; Herfs M; Delvenne P; Piérard GE
Future Oncol; 2015 Nov; 11(22):2997-3002. PubMed ID: 26437034
[TBL] [Abstract][Full Text] [Related]
5. Precision medicine and precision therapeutics: hedgehog signaling pathway, basal cell carcinoma and beyond.
Mohan SV; Chang AL
Semin Cutan Med Surg; 2014 Jun; 33(2):68-71. PubMed ID: 25085664
[TBL] [Abstract][Full Text] [Related]
6. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.
Kudchadkar R; Lewis K; Gonzalez R
Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185
[TBL] [Abstract][Full Text] [Related]
7. Hedgehog antagonist GDC-0449 is effective in the treatment of advanced basal cell carcinoma.
Amin SH; Tibes R; Kim JE; Hybarger CP
Laryngoscope; 2010 Dec; 120(12):2456-9. PubMed ID: 20927781
[TBL] [Abstract][Full Text] [Related]
8. Emerging treatments and signaling pathway inhibitors.
Tang JY; Marghoob AA
Semin Cutan Med Surg; 2011 Dec; 30(4 Suppl):S14-8. PubMed ID: 22177102
[TBL] [Abstract][Full Text] [Related]
9. Hedgehog Pathway Inhibition.
Sekulic A; Von Hoff D
Cell; 2016 Feb; 164(5):831. PubMed ID: 26919418
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog signaling in basal cell carcinoma.
Otsuka A; Levesque MP; Dummer R; Kabashima K
J Dermatol Sci; 2015 May; 78(2):95-100. PubMed ID: 25766766
[TBL] [Abstract][Full Text] [Related]
11. Hedgehog pathway inhibition and the race against tumor evolution.
Atwood SX; Chang AL; Oro AE
J Cell Biol; 2012 Oct; 199(2):193-7. PubMed ID: 23071148
[TBL] [Abstract][Full Text] [Related]
12. [Vismodegib in metastasized basal cell carcinoma].
Reinders MG; Dirix L; Mosterd K; van Doorn R
Ned Tijdschr Geneeskd; 2013; 157(12):A6011. PubMed ID: 23515044
[TBL] [Abstract][Full Text] [Related]
13. Oral hedgehog-pathway inhibitors for basal-cell carcinoma.
Lear JT
N Engl J Med; 2012 Jun; 366(23):2225-6. PubMed ID: 22670909
[No Abstract] [Full Text] [Related]
14. Hedgehog hopes lifted by approval... and stung by failure.
Allison M
Nat Biotechnol; 2012 Mar; 30(3):203. PubMed ID: 22398601
[No Abstract] [Full Text] [Related]
15. [Hedgehog inhibitors. New promising treatment of advanced basal cell carcinoma].
Wolodarski M; Lapins J; Hansson J
Lakartidningen; 2013 Apr 24-May 6; 110(17-18):886-8. PubMed ID: 23717940
[No Abstract] [Full Text] [Related]
16. Vismodegib: a hedgehog pathway inhibitor for locally advanced and metastatic basal cell carcinomas.
Sobanko JF; Okman J; Miller C
J Drugs Dermatol; 2013 Oct; 12(10 Suppl):s154-5. PubMed ID: 24085062
[TBL] [Abstract][Full Text] [Related]
17. Vismodegib (Erivedge) for basal cell carcinoma.
Med Lett Drugs Ther; 2012 Jul; 54(1394):53-4. PubMed ID: 22777303
[No Abstract] [Full Text] [Related]
18. Hedgehog signaling pathway: a novel target for cancer therapy: vismodegib, a promising therapeutic option in treatment of basal cell carcinomas.
Abidi A
Indian J Pharmacol; 2014; 46(1):3-12. PubMed ID: 24550577
[TBL] [Abstract][Full Text] [Related]
19. Vismodegib, a hedgehog pathway inhibitor for adults with locally advanced or metastatic basal cell carcinoma.
Wilkes GM
Oncology (Williston Park); 2012 Aug; 26(8 Suppl Nurse Ed):31-3. PubMed ID: 25375009
[No Abstract] [Full Text] [Related]
20. Sonic Hedgehog pathway inhibitors: from clinical trials to clinical practice.
Yan BY; Hibler BP; Menge T; Dunn L; Ho AL; Rossi AM
Br J Dermatol; 2019 May; 180(5):1260-1261. PubMed ID: 30693471
[No Abstract] [Full Text] [Related]
[Next] [New Search]
